Cargando…

Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer

A 64-year-old male patient with metastatic prostate carcinoma diagnosis received lutetium-177 prostate-specific membrane antigen (PSMA) treatment; however, his disease progressed. Herein, presented the final images of the patient that demonstrated a superscan appearance in the Gallium-68 PSMA positr...

Descripción completa

Detalles Bibliográficos
Autores principales: Koç, Zehra Pınar, Özcan, Pınar Pelin, Erçolak, Vehbi, Reyhan, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814547/
https://www.ncbi.nlm.nih.gov/pubmed/35114754
http://dx.doi.org/10.4274/mirt.galenos.2020.78800
_version_ 1784645087577243648
author Koç, Zehra Pınar
Özcan, Pınar Pelin
Erçolak, Vehbi
Reyhan, Mehmet
author_facet Koç, Zehra Pınar
Özcan, Pınar Pelin
Erçolak, Vehbi
Reyhan, Mehmet
author_sort Koç, Zehra Pınar
collection PubMed
description A 64-year-old male patient with metastatic prostate carcinoma diagnosis received lutetium-177 prostate-specific membrane antigen (PSMA) treatment; however, his disease progressed. Herein, presented the final images of the patient that demonstrated a superscan appearance in the Gallium-68 PSMA positron emission tomography/computed tomography, which is a rare phenomenon.
format Online
Article
Text
id pubmed-8814547
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-88145472022-02-16 Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer Koç, Zehra Pınar Özcan, Pınar Pelin Erçolak, Vehbi Reyhan, Mehmet Mol Imaging Radionucl Ther Interesting Image A 64-year-old male patient with metastatic prostate carcinoma diagnosis received lutetium-177 prostate-specific membrane antigen (PSMA) treatment; however, his disease progressed. Herein, presented the final images of the patient that demonstrated a superscan appearance in the Gallium-68 PSMA positron emission tomography/computed tomography, which is a rare phenomenon. Galenos Publishing 2022-02 2022-02-02 /pmc/articles/PMC8814547/ /pubmed/35114754 http://dx.doi.org/10.4274/mirt.galenos.2020.78800 Text en ©Copyright 2022 by Turkish Society of Nuclear Medicine | Molecular Imaging and Radionuclide Therapy published by Galenos Yayınevi. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Interesting Image
Koç, Zehra Pınar
Özcan, Pınar Pelin
Erçolak, Vehbi
Reyhan, Mehmet
Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
title Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
title_full Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
title_fullStr Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
title_full_unstemmed Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
title_short Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
title_sort superscan appearance of (68)ga psma pet/ct in a patient with refractory prostate cancer
topic Interesting Image
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814547/
https://www.ncbi.nlm.nih.gov/pubmed/35114754
http://dx.doi.org/10.4274/mirt.galenos.2020.78800
work_keys_str_mv AT koczehrapınar superscanappearanceof68gapsmapetctinapatientwithrefractoryprostatecancer
AT ozcanpınarpelin superscanappearanceof68gapsmapetctinapatientwithrefractoryprostatecancer
AT ercolakvehbi superscanappearanceof68gapsmapetctinapatientwithrefractoryprostatecancer
AT reyhanmehmet superscanappearanceof68gapsmapetctinapatientwithrefractoryprostatecancer